367 related articles for article (PubMed ID: 7754585)
1. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
[TBL] [Abstract][Full Text] [Related]
2. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
3. [Positron emission tomography in diagnosis of renal cell carcinoma].
Bachor R; Kotzerke J; Gottfried HW; Brändle E; Reske SN; Hautmann R
Urologe A; 1996 Mar; 35(2):146-50. PubMed ID: 8650849
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
5. Possible role of FDG-PET in the evaluation of urologic malignancies.
Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and monitoring of urological tumors using positron emission tomography.
Hofer C; Kübler H; Hartung R; Breul J; Avril N
Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
[TBL] [Abstract][Full Text] [Related]
7. [Lymph node staging of bladder neck carcinoma with positron emission tomography].
Bachor R; Kotzerke J; Reske SN; Hautmann R
Urologe A; 1999 Jan; 38(1):46-50. PubMed ID: 10081101
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Sherif A
Eur Urol; 2010 Apr; 57(4):647. PubMed ID: 19477582
[No Abstract] [Full Text] [Related]
9. FDG-PET for preoperative staging of bladder cancer.
Drieskens O; Oyen R; Van Poppel H; Vankan Y; Flamen P; Mortelmans L
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1412-7. PubMed ID: 16133380
[TBL] [Abstract][Full Text] [Related]
10. Pelvic cancers: staging of 139 cases with lymphography and fine-needle aspiration biopsy.
Chagnon S; Cochand-Priollet B; Gzaeil M; Jacquenod P; Roger B; Boccon-Gibod L; Blery M
Radiology; 1989 Oct; 173(1):103-6. PubMed ID: 2675176
[TBL] [Abstract][Full Text] [Related]
11. [Positron emission tomography in oncourology].
Ryzhkova DV; Granov AM; Karelin MI; Kostenikov NA; Shkol'nik MI; Tlostanova MS; Stanzhevskiĭ AA; Arzumanov AA
Vestn Ross Akad Med Nauk; 2005; (9):26-32. PubMed ID: 16250328
[TBL] [Abstract][Full Text] [Related]
12. False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
Decoene J; Winter C; Albers P
Urol Oncol; 2015 Jan; 33(1):23.e15-23.e21. PubMed ID: 25454484
[TBL] [Abstract][Full Text] [Related]
13. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Joice GA; Rowe SP; Gorin MA; Pierorazio PM
Curr Urol Rep; 2018 Nov; 19(12):110. PubMed ID: 30413968
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
15. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.
de Wit M; Brenner W; Hartmann M; Kotzerke J; Hellwig D; Lehmann J; Franzius C; Kliesch S; Schlemmer M; Tatsch K; Heicappell R; Geworski L; Amthauer H; Dohmen BM; Schirrmeister H; Cremerius U; Bokemeyer C; Bares R
Ann Oncol; 2008 Sep; 19(9):1619-23. PubMed ID: 18453520
[TBL] [Abstract][Full Text] [Related]
16. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
[TBL] [Abstract][Full Text] [Related]
17. [The lymph node staging of malignant testicular germ-cell tumors].
Krug B; Heidenreich A; Dietlein M; Lackner K
Rofo; 1999 Aug; 171(2):87-94. PubMed ID: 10506880
[TBL] [Abstract][Full Text] [Related]
18. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of recurrent genitourinary malignancies.
Greenberg RE; Charles RS; Samaha AM; Chelsky M; Rosen S
Semin Oncol; 1993 Oct; 20(5):473-92. PubMed ID: 8211196
[No Abstract] [Full Text] [Related]
20. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
